Stock Taper
SCREENER COMPARE ANY 2 STOCKS
CVS
CVS HEALTH CORP.
NYSE
$93.06
▲ UP 0.15% (0.14)

KEY STATISTICS

Market Cap$118.74 B
52w High$110.68
52w Low$69.51
Dividend Yield2.55%
FrequencyQuarterly
P/E11.87
Volume3.99M
Shares Out.1.28B

COMPANY

LEADERSHIP

J. David Joyner
CHIEF EXECUTIVE
J. David Joyner

COMPENSATION 2026

Salary$1,500,000
Stock Awards$14,499,931
Incentive Plan Pay$4,695,900
All Other Comp.$453,609
Total$21,214,084

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 21, 1973
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
259,500

PRICE TARGET

Target High$126.00
Target Low$92.00
Target Median$111.00
Target Consensus$110.47

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.$104.26B
NOV
4
WED

SPLIT RECORD

DATETYPERATIO
2005-06-07Forward2:1
1998-06-16Forward2:1
1989-03-15Forward2:1
1983-05-03Forward2:1

PRICE

$93.06 ▲ UP 0.15% (+$0.14)
OVERLAYS
$93.00$93.25$93.50$93.759:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM93.06

About CVS Health Corp.

https://www.cvshealth.com ↗

CVS Health Corporation provides comprehensive health services, including insurance, pharmacy benefit management, retail pharmacies, and walk-in clinics across approximately 9,900 locations in the U.S.

INDUSTRY

Medical - Healthcare Plans

A SERVICE CVS HEALTH CORP. IS KNOWN FOR

CVS Healthspire

CVS Healthspire, launched in late 2023, integrates CVS Health's care delivery assets and pharmacy services to provide a connected, value-based healthcare experience beyond retail and pharmacy benefits.

COMPETITORS

COMPETITOR
CI COMPARE
ELV COMPARE
HUM COMPARE
UNH COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Pharmacy Revenue$59.55B $61.62B ▲$56.94B ▼$60.83B ▲
Premiums$33.72B $34.02B ▲$33.79B ▼$35.12B ▲
Front Store Revenue$5.19B $5.66B ▲$5.26B ▼$5.41B ▲
Product and Service Other$1.02B $0 ▼$3.86B ▲$1.04B ▼
Corporate And Other Segment— — $126M —

ETFS HOLDING THIS STOCK

ETFS HOLDING
980
LISTED HERE
26
RANKED BY POSITION SIZE
VTS.AX
0.18% · 40.6M
IVV
0.18% · 17.0M
SPY
0.18% · 15.6M
FLCO
0.83% · 5.1M
VETS
3.65% · 4.8M
FNDX
0.78% · 2.3M
RWL
1.89% · 2.0M
CGUS
0.85% · 1.1M
JEPI
0.19% · 926.4K
XWD1.F
0.47% · 762.0K
LSPU.L
0.21% · 722.1K
DFUV
0.42% · 710.1K
DUSA
4.72% · 644.5K
RECS
0.93% · 612.2K
FHLC
1.62% · 610.5K
HMWO.L
0.26% · 529.3K
ZSP.TO
0.18% · 398.9K
DLN
0.53% · 360.0K
GSLC
0.19% · 317.6K
ETHI.AX
0.98% · 291.6K
SDOG
1.73% · 270.5K
WRDUSW.SW
0.13% · 240.8K
SPYI
0.18% · 227.6K
FTLS
0.70% · 189.2K
XHYH
1.85% · 140.0K
SEIM
0.83% · 132.0K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
59.37%
HOLDERS
3,116
TOP 12 OF 3,116 · RANKED BY POSITION SIZE
Blackrock, Inc.
125.9M sh · $9.04B
Vanguard Group Inc
120.7M sh · $9.58B
Blackrock Inc.
100.2M sh · $5.91B
Capital World Investors
77.2M sh · $5.55B
Dodge & Cox
73.2M sh · $5.52B
State Street Corp
60.3M sh · $6.24B
Fmr LLC
43.3M sh · $3.27B
Jpmorgan Chase & Co
35.3M sh · $2.66B
Wellington Management Group Llp
33.8M sh · $3.5B
Blackrock Institutional Trust Company, N.A.
30.1M sh · $2.38B
Geode Capital Management, LLC
29.9M sh · $3.08B
Capital International Investors
27.6M sh · $2.19B

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity3
Return On Assets3
Debt To Equity1
Price To Earnings1
Price To Book3
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Ro Khanna
Ro Khanna
Purchase
2026-06-02
SENATE TRADES
John Boozman
John Boozman
Purchase
2026-01-29
HOUSE TRADES
Michael McCaul
Michael McCaul
Sale
2026-01-13
 Dwight Evans
Dwight Evans
Sale
2025-11-21

INSIDER TRADES

★
OFFICER: SVP, CONT & CHIEF ACCT OFFICER
Clark James David
Sale · 454 shares
2026-06-26
★
OFFICER: EVP, CHIEF MEDICAL OFFICER
Compton-Phillips Amy
Sale · 7.6K shares
2026-05-31
★
OFFICER: EVP, CHIEF FINANCIAL OFFICER
Newman Brian
Sale · 2.5K shares
2026-05-31
★
DIRECTOR
AGUIRRE FERNANDO
Sale · 30.4K shares
2026-05-20

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OVERWEIGHT 6
BUY 5
OUTPERFORM 5
16 GRADES IN THE LAST 12 MONTHS
Argus Research BUY JP Morgan OVERWEIGHT Evercore ISI Group OUTPERFORM Barclays OVERWEIGHT UBS BUY Truist Securities BUY Wells Fargo OVERWEIGHT RBC Capital OUTPERFORM

SECTORS PEERS

PEERPRICE
VRTX$541.69COMPARE
BMY$66.58COMPARE
MDT$91.23COMPARE
MCK$893.39COMPARE
GSK$50.82COMPARE
HCA$417.82COMPARE
ELV$394.43COMPARE
CI$278.88COMPARE